Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Adinath Bio-Lab Ltd (590088)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590088 NSE: Trading | Small Cap | Adinath Bio-Lab Share Price
BSE Share Price
Not Listed
Not Listed
Adinath Bio-Lab Ltd (590088)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590088 NSE: Trading | Small Cap | Adinath Bio-Lab Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹7 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
40.3
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Steady versus 3-year growth rate
-100%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
25.75%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹22.1 Cr.
Face Value
₹1
All Time Low / High
₹0.15 / 29.70
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 7.4% | 3.2% | 2.5% | 2.4% | 0.5% | 0.6% | 1% | 0.2% | -52% | -34.3% | - |
| Value Creation Index ⓘ | -0.5 | -0.8 | -0.8 | -0.8 | -1.0 | -1.0 | -0.9 | -1.0 | -4.7 | -3.5 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 32.5 | 56.5 | 42.2 | 42.9 | 1 | 1.4 | 0.8 | 0.6 | 0.1 | 0 | 0 |
| Sales YoY Gr. | - | 73.7% | -25.3% | 1.6% | -97.7% | 35% | -40% | -30.9% | -91.1% | -100% | - |
| Adj EPS ⓘ | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.3 | -0.1 | -0.1 |
| YoY Gr. | - | -55.6% | -25% | 0% | -66.7% | 0% | -100% | NA | NA | NA | - |
| BVPS (₹) ⓘ | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 0.7 | 0.4 | 0.3 | 1.3 |
| Adj Net Profit ⓘ | 1.9 | 0.9 | 0.7 | 0.7 | 0.1 | 0.2 | 0 | 0 | -5.7 | -2.5 | -2 |
| Cash Flow from Ops. ⓘ | 1.1 | -1.4 | -1.3 | -0.1 | -0.1 | -0.1 | -2.6 | 0.1 | -0.5 | -0 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -100% | -100% | -100% | -100% | ||||
| Adj EPS ⓘ | -202.3% | -261.5% | NA | NA | ||||
| BVPSⓘ | -15% | -26.7% | -40.5% | -28.2% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 7.1 | 3.2 | 2.4 | 2.4 | 0.5 | 0.6 | 0 | 0.1 | -46.6 | -34 | -13.7 |
| Op. Profit Mgn % ⓘ | 6.8 | 1.8 | 2.6 | 2.2 | 27.4 | 27.8 | 33.9 | 25.5 | -1886 | 0 | 23.9 |
| Net Profit Mgn % ⓘ | 5.8 | 1.6 | 1.6 | 1.6 | 13.9 | 12.2 | 1.2 | 4.3 | -12065.2 | 0 | -INF |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 241 | 141 | 201 | 210 | 8,799 | 6,322 | 11,358 | 12,876 | 86,448 | 0 | 105 |
| Cash Conv. Cycle ⓘ | 154 | 79 | 96 | 97 | 3,853 | 1,433 | 242 | 636 | 7,576 | 0 | 60 |
Valuation of Adinath Bio-Lab - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Adinath Bio-Lab Ltd FAQs
The current trading price of Adinath Bio-Lab on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Adinath Bio-Lab stood at ₹6.62 Cr
The latest P/E ratio of Adinath Bio-Lab as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Adinath Bio-Lab as of 31-Dec-1969 is 0.23.
The 52-week high of Adinath Bio-Lab is ₹0.30 and the 52-week low is ₹0.30.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Adinath Bio-Lab is ₹0.00 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Adinath Bio-Lab Ltd
Adinath Bio Labs is a 27-year old organization, engaged in the manufacture of pharmaceutical raw materials and chemicals for the pharmaceutical and aromatic industries with an excellent track record in the domestic market.
Manufactured from premium quality raw materials, the company’s products are reputed for their high quality. Adinath Bio-Labs is listed on the Bombay Stock Exchange and the Calcutta Stock Exchange.
The company has established itself as one of the quality manufacturers of natural essential oils and pharmaceutical ingredients.
Adinath Bio-Labs main products in the essential oil division are mentha piperata, spearmint oil, basil oil, clove and eucalyptus oil. The manufacturing plant is situated at the outskirts of Mumbai. It is equipped with facilities for the manufacture of natural menthol and peppermint oil like liquid menthol, mentha oil, natural recryst flakes and crude menthol oil.
Along with menthol crystals, it also produces natural dementholised peppermint oil with the without terpenses as per customer specifications by using its world class fractional distillation columns. These columns are also used to produce terpenes cis-3-hexenol.menthone, liquid menthol as per customer’s requirement.
Products
- Mint Products - Under this, Adinath Bio-Labs produces products namely natural menthol BP/USP bold crystals, natural menthol USP medium crystals, natural recryst flakes, natural melted menthol, crude mentha oil natural, liquid menthol, dementholised peppermint oil and peppermint oil.
- Essential Oil Products - Under this company produces menthones, Cis-3-Hexenol, mentha piperata natural, spearmint oil-carvone, anethole cis-anethole and basil oil natural.
- Other Products - The company manufactures carboxylic acids / dicarboxylic acids, laboratory reagents, morpholine / phenanthroline, quinoline / isoquinolines, phenol / resorcinol / anisole and chemical compounds.
Adinath Bio-Labs’ R&D capability is a vital component for its entire business operations, as it provides a sustainable, long-term and competitive advantage to the company.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
